Skip to main content
NCBI home page
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1970;43(Suppl):66–76.

Amphetamines

PMCID: PMC2427604  PMID: 20604377

Full text

PDF
66

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BELL D. S., TRETHOWAN W. H. Amphetamine addiction. J Nerv Ment Dis. 1961 Dec;133:489–496. doi: 10.1097/00005053-196112000-00003. [DOI] [PubMed] [Google Scholar]
  2. Bell D. S. Addiction to stimulants. Med J Aust. 1967 Jan 14;1(2):41–45. [PubMed] [Google Scholar]
  3. CAPLAN J. Habituation to diethylpropion (Tenuate). Can Med Assoc J. 1963 May 4;88:943–944. [PMC free article] [PubMed] [Google Scholar]
  4. CLEIN L. J., BENADY D. R. Case of diethylpropion addiction. Br Med J. 1962 Aug 18;2(5302):456–456. doi: 10.1136/bmj.2.5302.456. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Connell P. H. Amphetamine dependence. Proc R Soc Med. 1968 Feb;61(2):178–181. doi: 10.1177/003591576806100228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Connell P. H. The use and abuse of amphetamines. Practitioner. 1968 Feb;200(196):234–243. [PubMed] [Google Scholar]
  7. DARLING H. F. Addiction to phenmetrazine hydrochloride. Am J Psychiatry. 1961 Dec;118:558–558. doi: 10.1176/ajp.118.6.558. [DOI] [PubMed] [Google Scholar]
  8. Edison C. R. Abuse of amphetamines. JAMA. 1968 Sep 16;205(12):882–883. [PubMed] [Google Scholar]
  9. Foxwell M. H., Funderburk W. H., Ward J. W. Studies on the site of action of a new anorectic agent, fenfluramine. J Pharmacol Exp Ther. 1969 Jan;165(1):60–70. [PubMed] [Google Scholar]
  10. GYLYS J. A., HART J. J., WARREN M. R. Chlorphentermine, a new anorectic agent. J Pharmacol Exp Ther. 1962 Sep;137:365–373. [PubMed] [Google Scholar]
  11. Gagnon M. A., Bordeleau J. M., Tétreault L. Fenfluramine: study of its central action through its effects on sleep. Int Z Klin Pharmakol Ther Toxikol. 1969 Jan;2(1):74–82. [PubMed] [Google Scholar]
  12. Glatt M. M. Abuse of methylamphetamine. Lancet. 1968 Jul 27;2(7561):215–216. doi: 10.1016/s0140-6736(68)92646-9. [DOI] [PubMed] [Google Scholar]
  13. Griffith J. A study of illicit amphetamine drug traffic in Oklahoma City. Am J Psychiatry. 1966 Nov;123(5):560–569. doi: 10.1176/ajp.123.5.560. [DOI] [PubMed] [Google Scholar]
  14. Hart R. Problems in amphetamine usage. Br Med J. 1968 May 18;2(5602):432–432. doi: 10.1136/bmj.2.5602.432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hauffmann M., Gylling B., Graubner W. Negligerar preludin-företaget missbruket? Lakartidningen. 1966 Jan 19;63(3):213–216. [PubMed] [Google Scholar]
  16. Hawks D., Mitcheson M., Ogborne A., Edwards G. Abuse of methylamphetamine. Br Med J. 1969 Jun 21;2(5659):715–721. doi: 10.1136/bmj.2.5659.715. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Herold E., Kemper F., Opitz K. Einfluss appetithemmender Substanzen auf Kohlenhydrat- und Fettsäurestoffwechsel. Arzneimittelforschung. 1965 Jun;15(6):657–659. [PubMed] [Google Scholar]
  18. Herulf B., Sunesson T. Unga narkotikamissbrukare i Stockholm. Lakartidningen. 1967 May 10;64(19):1936–1942. [PubMed] [Google Scholar]
  19. James I. P. A methylamphetamine epidemic? Lancet. 1968 Apr 27;1(7548):916–916. doi: 10.1016/s0140-6736(68)90262-6. [DOI] [PubMed] [Google Scholar]
  20. Jersild T., Ott C., Thiede J. Inokulationshepatitis hos narkomaner og efter tatovering. Yngre Laeger. 1967 Dec 7;13(24):1664–1665. [PubMed] [Google Scholar]
  21. Johnson J., Milner G. Amphetamine intoxication and dependence in admissions to a psychiatric unit. Br J Psychiatry. 1966 Jun;112(487):617–619. doi: 10.1192/bjp.112.487.617. [DOI] [PubMed] [Google Scholar]
  22. Johnson J., Milner G. Psychiatric complications of amphetamine substances. Acta Psychiatr Scand. 1966;42(3):252–263. doi: 10.1111/j.1600-0447.1966.tb01930.x. [DOI] [PubMed] [Google Scholar]
  23. Knoll J., Vizi E. S., Ecseri Z. Psychomimetic methylamphetamine derivatives. Arch Int Pharmacodyn Ther. 1966 Feb;159(2):442–451. [PubMed] [Google Scholar]
  24. Kramer J. C., Fischman V. S., Littlefield D. C. Amphetamine abuse. Pattern and effects of high doses taken intravenously. JAMA. 1967 Jul 31;201(5):305–309. doi: 10.1001/jama.201.5.305. [DOI] [PubMed] [Google Scholar]
  25. Lachnit V. Zur Anwendung sogenannter Appetitzügler. Wien Z Inn Med. 1965 Jun;46(6):248–254. [PubMed] [Google Scholar]
  26. Ladewig D., Battegay R., Labhardt F. Stimulantien: Abhängigkeit und Psychosen. Dtsch Med Wochenschr. 1969 Jan 17;94(3):101–107. doi: 10.1055/s-0028-1108909. [DOI] [PubMed] [Google Scholar]
  27. Lemere F. The danger of amphetamine dependency. Am J Psychiatry. 1966 Nov;123(5):569–572. doi: 10.1176/ajp.123.5.569. [DOI] [PubMed] [Google Scholar]
  28. Maffii G., Banfi S. Osservazioni sperimentali sull'abitudine e i fenomeni di astinenza nel ratto trattato con analgesici. Boll Chim Farm. 1966 Oct;105(10):739–745. [PubMed] [Google Scholar]
  29. Moorehead N. C. Amphetamine consumption in Northern Ireland. J Ir Med Assoc. 1968 Mar;61(369):80–84. [PubMed] [Google Scholar]
  30. Nemetz P. S. Phenmetrazine psychosis. Br Med J. 1968 Sep 28;3(5621):803–804. doi: 10.1136/bmj.3.5621.803-e. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Nemirovskii D. E. O gratsidinomanii. Vrach Delo. 1965 Jul;7:145–147. [PubMed] [Google Scholar]
  32. Ney P. G. Psychosis in a child, associated with amphetamine administration. Can Med Assoc J. 1967 Oct 21;97(17):1026–1029. [PMC free article] [PubMed] [Google Scholar]
  33. Oehme P., Lock W. Arzneimittelmissbrauch und Sucht. Z Arztl Fortbild (Jena) 1966 Jul 1;60(13):781–790. [PubMed] [Google Scholar]
  34. Osuka T., Shimizu T., Utena H. [Brain ATPase in chronic poisoning induced by amphetamine in mice]. Shinkei Kenkyu No Shimpo. 1966 Jul;10(2):224–226. [PubMed] [Google Scholar]
  35. Oswald I., Jones H. S., Mannerheim J. E. Effects of two slimming drugs on sleep. Br Med J. 1968 Mar 30;1(5595):796–799. doi: 10.1136/bmj.1.5595.796. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Pickens R., Harris W. C. Self-administration of d-amphetamine by rats. Psychopharmacologia. 1968;12(2):158–163. doi: 10.1007/BF00401545. [DOI] [PubMed] [Google Scholar]
  40. Rosenberg C. M. Young drug addicts: addiction and its consequences. Med J Aust. 1968 Jun 15;1(24):1031–1033. doi: 10.5694/j.1326-5377.1968.tb29116.x. [DOI] [PubMed] [Google Scholar]
  41. Rossi A., Montanari G. Manifestazioni patologiche dentali nell'intossicazione cronica da sostanza amfetaminiche. Controlli clinici e sperimentali. Mondo Odontostomatol. 1966 Apr;8(2):183–188. [PubMed] [Google Scholar]
  42. Rylander G. Preludin-narkomaner från klinisk och medicinsk-kriminologisk synpunkt. Lakartidningen. 1966 Dec 28;63(52):4973–4980. [PubMed] [Google Scholar]
  43. Scott P. D., Willcox D. R. Delinquency and the amphetamines. Br J Psychiatry. 1965 Sep;111(478):865–875. doi: 10.1192/bjp.111.478.865. [DOI] [PubMed] [Google Scholar]
  44. Silverstone J. T., Stunkard A. J. The anorectic effect of dexamphetamine sulphate. Br J Pharmacol Chemother. 1968 Jul;33(3):513–522. doi: 10.1111/j.1476-5381.1968.tb00499.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. TOLENTINO I., D'AVOSSA B. Psicosi da amine simpatico-mimetiche; studio clinico e psicopatologico. Arch Psicol Neurol Psichiatr. 1957 Mar-Apr;18(2):127–169. [PubMed] [Google Scholar]
  46. Takács L. Gracidin mámor--pondex psychosis. (Adatok az anorexigének okozta psychopathologiai tünetekhez) Orv Hetil. 1965 Aug 22;106(34):1611–1613. [PubMed] [Google Scholar]
  47. Utena H. Behavioral aberrations in methamphetamine-intoxicated animals and chemical correlates in the brain. Prog Brain Res. 1966;21:192–207. doi: 10.1016/s0079-6123(08)64231-4. [DOI] [PubMed] [Google Scholar]
  48. Vencovský E., Nevole S. Problematika dopingu fenmetrazinem. Cesk Psychiatr. 1965 Dec;61(6):411–414. [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES